Pneumococcal vaccines for preventing otitis media (Q24247465)

Europe PubMed Central

title

Pneumococcal vaccines for preventing otitis media (English)

0 references

1 reference

Masja M Straetemans

1

0 references

Elisabeth AM Sanders

2

0 references

Reinier H Veenhoven

3

0 references

Anne GM Schilder

4

0 references

Roger AMJ Damoiseaux

5

0 references

Gerhard GA Zielhuis

Cochrane Database of Systematic Reviews

6

0 references

publication date

26 January 2004

0 references

published in

0 references

cites work

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Impact of the pneumococcal conjugate vaccine on otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Prevention of otitis media in children by pneumococcal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Effect of 23 valent pneumococcal polysaccharide and Haemophilus influenza conjugated vaccines on the clinical course of otitis media with effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Treatment of acute otitis media - challenges in the era of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Pneumococcal conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Diagnosis and antibiotic treatment of acute otitis media: report from International Primary Care Network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Overall cost in the treatment of otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Recurrent acute otitis media: the significance of age at onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Assessing immune responses to pneumococcal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Sequelae of recurrent acute otitis media. Ten-year follow-up of a prospectively studied cohort of children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

The effect of a pneumococcal conjugate vaccine on the risk of otitis media with effusion at 7 and 24 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years. Greater Boston Otitis Media Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Pneumococcal vaccines for preventing otitis media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

Generalized Linear Models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

Pneumococcal vaccine and otitis media

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

Beneficial effect of pneumococcal vaccination on otitis media in children over two years old

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

Clinical Studies of Pneumococcal Vaccines in Infants. II. Efficacy and Effect on Nasopharyngeal Carriage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

Use of pneumococcal vaccine for prevention of recurrent acute otitis media in infants in Boston. The Greater Boston Collaborative Otitis Media Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

Efficacy of Pneumococcal Polysaccharide Vaccine in Preventing Acute Otitis Media in Infants in Huntsville, Alabama

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

A study of the pneumococcal vaccine in prevention of clinically acute atttacks of recurrent otitis media.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

Vaccination against Streptococcus pneumoniae in childhood: lack of demonstrable benefit in young Australian children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

Prophylaxis of otitis media in asthmatic children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

Pneumococcal vaccine in aboriginal children--a randomized controlled trial involving 60 children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

Efficacy of pneumococcal vaccination against recurrent otitis media. Preliminary results of a field trial in Finland

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021

The Bacteriology of Acute Otitis Media in Children with Special Reference to Streptococcus Pneumoniae as Studied by Bacteriological and Antigen Detection Methods

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001480.PUB2

7 January 2021